This mother’s day, was the 50th anniversary of the Food and Drug Administration’s approval of the birth control pill. The pill has had an enormous impact on reproductive freedoms, enabling women to take control of their own fertility. But some…
Lawsuits against pharmaceutical companies that manufacture prescription birth control aren’t new. Recently, we saw the mass tort suits against Ortho Evra, the birth control patch, because the patch was causing stroke and death in otherwise healthy women. Now Bayer’s Yaz and Yasmin are are being scrutinized, for pretty much the same reason.
As it turns out, Yaz and Yasmin might be responsible for causing stroke, heart attack, deep vein thrombosis, and pulmonary embolism–all blood-clot related problems. There have also been gallbladder and kidney problems reported with use of these drugs.
The litigation is still in its beginning stages. Thirty-two federal lawsuits have been filed, and there will be a hearing on September 24th to decide whether or not these cases should be consolidated into multi-district litigation (MDL) in the Northern District of Ohio. Several state cases have also been filed.
GJEL is currently investigating potential claims against Bayer because of Yaz and Yasmin. Because of his expertise on the matter, Andrew Gillin, partner at GJEL was recently quoted by US Recall News about the litigation. He explained that at the hearing on September 24th, “a panel of federal judges will determine whether the cases involve sufficiently common questions of fact, and whether or not to consolidate.”
photo courtesy of notfamousyet on flickr.com